Follow
Michael H. Nelson
Michael H. Nelson
Chair and Associate Professor, Pharmaceutical Sciences, Regis University
Verified email at regis.edu - Homepage
Title
Cited by
Cited by
Year
Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors
MH Nelson, CR Dolder
Annals of Pharmacotherapy 40 (2), 261-269, 2006
2432006
Hypnosedative-induced complex behaviours: incidence, mechanisms and management
CR Dolder, MH Nelson
CNS drugs 22, 1021-1036, 2008
1842008
Paliperidone for schizophrenia
C Dolder, M Nelson, Z Deyo
American Journal of Health-System Pharmacy 65 (5), 403-413, 2008
942008
Agomelatine treatment of major depressive disorder
CR Dolder, M Nelson, M Snider
Annals of Pharmacotherapy 42 (12), 1822-1831, 2008
902008
Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?
C Dolder, M Nelson, J McKinsey
CNS drugs 21, 389-405, 2007
892007
Deliberate integration of student leadership development in doctor of pharmacy programs
KK Janke, MH Nelson, AS Bzowyckyj, DG Fuentes, E Rosenberg, ...
American Journal of Pharmaceutical Education 80 (1), 2, 2016
642016
Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors
MH Nelson, AK Birnbaum, RP Remmel
Epilepsy research 44 (1), 71-82, 2001
582001
Including emotional intelligence in pharmacy curricula to help achieve CAPE outcomes
MH Nelson, KK Fierke, BJ Sucher, KK Janke
American journal of pharmaceutical education 79 (4), 48, 2015
572015
Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients
C Dolder, M Nelson, A Stump
Drugs & aging 27, 625-640, 2010
532010
The effects of mirtazapine on sleep in patients with major depressive disorder
CR Dolder, MH Nelson, CA Iler
, 24, 3 24 (3), 215-224, 2012
472012
The Regis Model for pharmacy education: A highly integrated curriculum delivered by Team-Based Learning™(TBL)
M Nelson, SD Allison, M McCollum, SW Luckey, DR Clark, SM Paulsen, ...
Currents in Pharmacy Teaching and Learning 5 (6), 555-563, 2013
432013
Variations in parthenolide content and daily dose of feverfew products
MH Nelson, SE Cobb, J Shelton
American journal of health-system pharmacy 59 (16), 1527-1531, 2002
422002
Prevnar 13, the new 13-valent pneumococcal conjugate vaccine
AJ Sucher, EB Chahine, M Nelson, BJ Sucher
Annals of Pharmacotherapy 45 (12), 1516-1524, 2011
412011
Team-based learning in pharmacy: The faculty experience
S Tweddell, D Clark, M Nelson
Currents in Pharmacy Teaching and Learning 8 (1), 7-17, 2016
372016
An elective course in leader development
B Sucher, M Nelson, D Brown
American Journal of Pharmaceutical Education 77 (10), 224, 2013
362013
Assessing emotionally intelligent leadership in pharmacy students
RC Haight, C Kolar, MH Nelson, KK Fierke, BJ Sucher, KK Janke
American journal of pharmaceutical education 81 (2), 29, 2017
302017
Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C
LS Smith, M Nelson, S Naik, J Woten
Annals of Pharmacotherapy 45 (5), 639-648, 2011
292011
A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer
MH Nelson, CR Dolder
Therapeutics and Clinical Risk Management 3 (4), 665-673, 2007
272007
Certolizumab pegol: a TNF-α antagonist for the treatment of moderate-to-severe Crohn's disease
LS Smith, M Nelson, CR Dolder
Annals of Pharmacotherapy 44 (2), 333-342, 2010
232010
A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies1
MH Nelson, AK Birnbaum, PJ Nyhus, RP Remmel
Journal of pharmaceutical and biomedical analysis 17 (8), 1311-1323, 1998
181998
The system can't perform the operation now. Try again later.
Articles 1–20